共 271 条
[1]
Kuchenbaecker KB(2017)Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers JAMA 317 2402-2416
[2]
Hopper JL(2020)NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian and pancreatic, version 1.2020 J Natl Compr Cancer Netw 18 380-391
[3]
Barnes DR(1999)The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews Am J Hum Genet 64 963-970
[4]
Daly MB(2001)The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations Cancer Epidemiol Biomark Prev 10 467-473
[5]
Pilarski R(2000)BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66 1259-1272
[6]
Yurgelun MB(1999)Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 91 1241-1247
[7]
Hartge P(2011)Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population Ann Oncol 22 964-966
[8]
Struewing JP(2003)Hereditary colorectal cancer N Engl J Med 348 919-932
[9]
Wacholder S(2001)The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas Am J Hum Gene 69 780-790
[10]
Brody LC(2011)Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome JAMA 305 2304-2310